CRLCharles River Laboratories International, Inc.
160.30USD+0.91%Mkt Cap: 7.72B USDP/E: Last update: 2026-05-22

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Mode…

Indicators:|

Key Statistics

Company
Market Cap7.72B USD
Enterprise Value10.57B USD
Revenue (TTM)4.03B USD
Gross Profit1.32B USD
Net Income (TTM)-144.34M USD
Revenue/Share81.96 USD
Last Price160.30 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees18.3K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS1598641074
Valuation
P/E (Trailing)
P/E (Forward)12.91
PEG0.12
EV/EBITDA11.88
EV/Revenue2.63
P/S1.90
P/B2.60
EPS (TTM)-3.72
EPS (Forward)12.31
52W Range
132.5829% of range228.88
52W High228.88 USD
52W Low132.58 USD
Profitability
Gross Margin32.96%
Oper. Margin15.92%
EBITDA Margin22.09%
Profit Margin-3.59%
ROE-4.56%
ROA-2.02%
Growth
Revenue Growth1.20%
Earnings Growth
Cash Flow & Leverage
Operating CF737.65M USD
CapEx (TTM)219.15M USD
FCF Margin12.66%
FCF Yield6.61%
Net Debt2.87B USD
Net Debt/EBITDA3.23
Balance Sheet
Debt/Equity0.81
Current Ratio1.36
Quick Ratio0.82
Book Value/Sh61.05 USD
Cash/Share3.983 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)208.80 USD
Target Range135.00 USD265.00 USD
# Analysts15
Ownership
Shares Out.48.17M
Float47.59M
Insiders0.95%
Institutions123.72%
Short Interest
Short Ratio4.1d
Short % Float8.02%
Short % Out.6.95%
Shares Short3.35M
Short (prev mo.)4.59M
Technical
SMA 50167.61 (-4.4%)
SMA 200175.82 (-8.8%)
Beta1.45
S&P 52W Chg28.31%
Avg Vol (30d)870.35K
Avg Vol (10d)989.04K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)